🇺🇸 FDA
Patent

US 10328109

Targeted adenoviruses and methods of making, isolating, and using

granted A61KA61K35/761

Quick answer

US patent 10328109 (Targeted adenoviruses and methods of making, isolating, and using) held by Regents of the University of Minnesota expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/761